Cargando…

The response prediction and prognostic values of systemic inflammation response index in patients with advanced lung adenocarcinoma

PURPOSE: This study aimed to assess the response prediction and prognostic values of different peripheral blood cell biomarkers for advanced lung adenocarcinoma (LUAD) patients receiving first‐line therapy. METHODS: Patients diagnosed with advanced LUAD as well as healthy controls and patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zuo, Ran, Zhu, Fuyi, Zhang, Cuicui, Ma, Jincheng, Chen, Jinliang, Yue, Ping, Cui, Jinfang, Wang, Yu, Chen, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234781/ https://www.ncbi.nlm.nih.gov/pubmed/37128769 http://dx.doi.org/10.1111/1759-7714.14893

Ejemplares similares

A Pan-Cancer Analysis of the Oncogenic Role of Twinfilin Actin Binding Protein 1 in Human Tumors
por: Huo, Gengwei, et al.
Publicado: (2021)

The prognostic value of the advanced lung cancer inflammation index (ALI) for patients with neuroblastoma
por: Qi, Can, et al.
Publicado: (2022)

Prognostic Value of the Systemic Inflammation Response Index in Patients with Adenocarcinoma of the Oesophagogastric Junction: A Propensity Score-Matched Analysis
por: Chen, Yuan, et al.
Publicado: (2019)

Prognostic value of the systemic inflammation response index in patients with acute ischemic stroke
por: Zhou, Yaping, et al.
Publicado: (2022)

Prognostic value of systemic inflammation response index in nasopharyngeal carcinoma with negative Epstein-Barr virus DNA
por: Yuan, Xiaofei, et al.
Publicado: (2022)

The Prognostic Value of Systemic Inflammation Response Index in Cholangiocarcinoma Patients
por: Jin, Bao, et al.
Publicado: (2021)

Prognostic value of the systemic inflammation response index in human malignancy: A meta-analysis
por: Wei, Lishuang, et al.
Publicado: (2020)

High incidence and reversible bradycardia events following alectinib initiation
por: Yuan, Dongqi, et al.
Publicado: (2022)

Prognostic value of systemic inflammation response index in hepatoblastoma patients receiving preoperative neoadjuvant chemotherapy
por: Zheng, Chen, et al.
Publicado: (2023)

The prognostic value of the advanced lung cancer inflammation index in patients with gastrointestinal malignancy
por: Zhang, Lilong, et al.
Publicado: (2023)

Prognostic Values of Systemic Inflammation Response (SIR) Parameters in Resectable Cervical Cancer
por: Wang, Wen-Jie, et al.
Publicado: (2019)

Prognostic Value of the Advanced Lung Cancer Inflammation Index in Patients with Lung Cancer: A Meta-Analysis
por: Zhang, Yi, et al.
Publicado: (2019)

Prognostic Value of the Pretreatment Systemic Immune-Inflammation Index in Patients with Colorectal Cancer
por: Li, Jing, et al.
Publicado: (2020)

Response to tyrosine kinase inhibitors in lung adenocarcinoma with the rare epidermal growth factor receptor mutation S768I and G724S: A case report and literature review
por: Zhang, Cuicui, et al.
Publicado: (2020)

Prognostic Value of the Systemic Immune-Inflammation Index and Prognostic Nutritional Index in Patients With Medulloblastoma Undergoing Surgical Resection
por: Zhu, Sihan, et al.
Publicado: (2021)

Inetetamab, a novel anti-HER2 monoclonal antibody, exhibits potent synergistic anticancer effects with cisplatin by inducing pyroptosis in lung adenocarcinoma
por: Cui, Jinfang, et al.
Publicado: (2023)

The prognostic value of advanced lung cancer inflammation index (ALI) in elderly patients with heart failure
por: Yuan, Xiao, et al.
Publicado: (2022)

The Prognostic Value of the Acute Phase Systemic Immune–Inflammation Index in Patients With Intracerebral Hemorrhage
por: Li, Yunke, et al.
Publicado: (2021)

Prognostic value of postdiagnostic inflammation-based scores in short-term overall survival of advanced pancreatic ductal adenocarcinoma patients
por: Xiao, Yuanyuan, et al.
Publicado: (2017)

The Prognostic Value of Preoperative Geriatric Nutritional Risk Index in Patients with Pancreatic Ductal Adenocarcinoma
por: Hu, Si-Pin, et al.
Publicado: (2020)

Prognostic value of systemic immune-inflammation index in patients with gastric cancer
por: Wang, Kang, et al.
Publicado: (2017)

Pan-Immune-Inflammation Value: A New Prognostic Index in Operative Breast Cancer
por: Lin, Fei, et al.
Publicado: (2022)

The Prognostic Value of the Prognostic Nutritional Index in Patients with Advanced or Metastatic Gastric Cancer Treated with Immunotherapy
por: Pan, Yuting, et al.
Publicado: (2023)

The Prognostic Value and Potential Mechanism of Tumor-Nutrition-Inflammation Index and Genes in Patients with Advanced Lung Cancer
por: Wang, Huan, et al.
Publicado: (2023)

EGFR exon 20 insertion mutation in advanced thymic squamous cell carcinoma: Response to apatinib and clinical outcomes
por: Yudong, Su, et al.
Publicado: (2018)

Prognostic Value of the Systemic Inflammatory Response Index in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Population-Based Study
por: Ni, Jinliang, et al.
Publicado: (2021)

Distinct molecular phenotype and the potential prognostic value of immune prognostic index and tumor infiltrating lymphocytes in hepatoid adenocarcinoma of stomach
por: Kang, Muxing, et al.
Publicado: (2022)

Exploring the value of new preoperative inflammation prognostic score: white blood cell to hemoglobin for gastric adenocarcinoma patients
por: Zheng, Hua-Long, et al.
Publicado: (2019)

Prognostic value of immune related genes in lung adenocarcinoma
por: Wang, Han, et al.
Publicado: (2020)

Prognostic value of systemic immune-inflammation index/ albumin for transcatheter arterial chemoembolization treatment
por: Tian, Yali, et al.
Publicado: (2023)

A Metabolism-Related Gene Prognostic Index for Prediction of Response to Immunotherapy in Lung Adenocarcinoma
por: Tang, Bo, et al.
Publicado: (2022)

Evidence of the Prognostic Value of Pretreatment Systemic Inflammation Response Index in Cancer Patients: A Pooled Analysis of 19 Cohort Studies
por: Zhang, Yi, et al.
Publicado: (2020)

Prognostic capacity of the systemic inflammation response index for functional outcome in patients with aneurysmal subarachnoid hemorrhage
por: Hou, Yuyang, et al.
Publicado: (2023)

Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Gastric Cancer: A Meta-Analysis
por: Qiu, Ye, et al.
Publicado: (2021)

Systemic Inflammation Response Index (SIRI) Independently Predicts Survival in Advanced Lung Adenocarcinoma Patients Treated with First-Generation EGFR-TKIs
por: Jiang, Shun, et al.
Publicado: (2021)

A bioinformatics-based immune-related prognostic index for lung adenocarcinoma that predicts patient response to immunotherapy and common treatments
por: Wang, Chenghao, et al.
Publicado: (2022)

Use of the Advanced Lung Cancer Inflammation Index as a Prognostic Indicator for Patients With Cholangiocarcinoma
por: Wu, Huasheng, et al.
Publicado: (2022)

The systemic inflammation response index predicts survival and recurrence in patients with resectable pancreatic ductal adenocarcinoma
por: Li, Shuo, et al.
Publicado: (2019)

Prognostic value of the systematic immune-inflammation index among patients with operable colon cancer: A retrospective study
por: Tao, Ming-Yue, et al.
Publicado: (2018)

The prognostic value of the systemic immune-inflammation index for patients with bladder cancer after radical cystectomy
por: Zhang, Shiyu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4tojtqgq281mr87theq5flu37p